INT83799

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.82
First Reported 1999
Last Reported 2010
Negated 0
Speculated 1
Reported most in Abstract
Documents 8
Total Number 10
Disease Relevance 7.86
Pain Relevance 2.23

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cell proliferation (Bcl2l1) cytosol (Bcl2l1) mitochondrion (Bcl2l1)
growth (Bcl2l1) cytoskeleton (Bcl2l1) intracellular (Bcl2l1)
Anatomy Link Frequency
band 3
liver 1
spleens 1
Bcl2l1 (Mus musculus)
Pain Link Frequency Relevance Heat
Paracetamol 33 99.50 Very High Very High Very High
Clonidine 9 91.36 High High
cerebral cortex 3 75.00 Quite High
antagonist 2 40.60 Quite Low
fibrosis 3 30.88 Quite Low
cva 1 12.16 Low Low
Kinase C 5 5.00 Very Low Very Low Very Low
cytokine 5 5.00 Very Low Very Low Very Low
Parenteral administration 2 5.00 Very Low Very Low Very Low
Chronic pancreatitis 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Apoptosis 65 100.00 Very High Very High Very High
Hypoxia 33 100.00 Very High Very High Very High
Cancer 121 98.24 Very High Very High Very High
Toxicity 4 97.20 Very High Very High Very High
Death 23 91.68 High High
Reprotox - General 1 39 89.48 High High
Necrosis 5 84.00 Quite High
Pancreatic Cancer 64 82.80 Quite High
Injury 5 76.36 Quite High
Congenital Anomalies 18 73.36 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
As the toxicity progressed, during 6 and 18 h post-AAP administration, the BCL-X(L) protein band shifted to a slower mobility band which might represent a phosphorylated form of BCL-X(L).
Phosphorylation (phosphorylated) of BCL-X in band associated with toxicity and paracetamol
1) Confidence 0.82 Published 2000 Journal Arch. Toxicol. Section Abstract Doc Link 10663392 Disease Relevance 1.08 Pain Relevance 0.46
As the toxicity progressed, during 6 and 18 h post-AAP administration, the BCL-X(L) protein band shifted to a slower mobility band which might represent a phosphorylated form of BCL-X(L).
Phosphorylation (form) of BCL-X in band associated with toxicity and paracetamol
2) Confidence 0.63 Published 2000 Journal Arch. Toxicol. Section Abstract Doc Link 10663392 Disease Relevance 1.02 Pain Relevance 0.46
The most dramatic changes observed in this study were: (i) substantial increase in the expression of bcl-Xl in the liver by 7-day GSPE exposure alone; (ii) significant modification bcl-Xl expression by AAP alone; and (iii) dramatic inhibition of AAP-induced modification of bcl-Xl (phosphorylation?)
Phosphorylation (phosphorylation) of bcl-Xl in liver associated with paracetamol
3) Confidence 0.53 Published 1999 Journal Arch. Biochem. Biophys. Section Abstract Doc Link 10462439 Disease Relevance 0.50 Pain Relevance 0.67
There was constitutive activation of Stat5 and detectable expression of the Stat5 target Bcl-XL in BM of both normal and polycythemic mice, with increased Stat5 phosphorylation and Bcl-XL in spleens from JAKV617F recipients, although this could in part reflect the increase in splenic myeloerythroid cells in these mice.
Phosphorylation (phosphorylation) of Bcl-XL in spleens
4) Confidence 0.41 Published 2006 Journal PLoS ONE Section Body Doc Link PMC1762384 Disease Relevance 0.25 Pain Relevance 0
As expected levels of phosphorylated AKT, Bcl-2, Bcl-xL and survivin were significantly reduced in tumors from mice treated with the reg4 antibody compared to control.
Phosphorylation (phosphorylated) of Bcl-xL associated with cancer
5) Confidence 0.15 Published 2009 Journal PLoS ONE Section Body Doc Link PMC2760775 Disease Relevance 1.00 Pain Relevance 0
JNK when activated can phosphorylate serine 62 on Bcl-xL, which effectively prevents this protein's anti-apoptotic effects [56].
Phosphorylation (phosphorylate) of Bcl-xL associated with apoptosis
6) Confidence 0.14 Published 2004 Journal Cell Commun Signal Section Body Doc Link PMC449737 Disease Relevance 0.37 Pain Relevance 0
Because systemic treatment with the antibody reduces tumor growth and increases sensitivity to gemcitabine treatment, we used western blot analysis to monitor in tumors the influence of reg4 antibody treatment on the intracellular levels of proteins associated with apoptosis (phosphorylated AKT, Bcl-2, Bcl-xL and survivin) and cell cycle (cyclin D1).
Phosphorylation (phosphorylated) of Bcl-xL associated with cancer and apoptosis
7) Confidence 0.13 Published 2009 Journal PLoS ONE Section Body Doc Link PMC2760775 Disease Relevance 1.06 Pain Relevance 0
Cytosol was isolated and separated by 12% SDS-PAGE and probed with tyrosine phosphorylated (p) -Bax, Bad, Bcl-2 and Bcl-xl antibodies and bands were detected.
Phosphorylation (phosphorylated) of Bcl-xl in bands
8) Confidence 0.08 Published 2010 Journal Neurochem. Res. Section Abstract Doc Link 19597709 Disease Relevance 0.84 Pain Relevance 0.22
The present study aims to investigate the mechanism of phosphorylation of apoptotic proteins and tests the hypothesis that the hypoxia-induced increased tyrosine phosphorylation of apoptotic proteins Bcl-2 and Bcl-xl is Ca(2+)-influx-dependent.
Spec (investigate) Phosphorylation (phosphorylation) of Bcl-xl associated with hypoxia and apoptosis
9) Confidence 0.08 Published 2010 Journal Neurochem. Res. Section Abstract Doc Link 19597709 Disease Relevance 0.88 Pain Relevance 0.21
The present study aims to investigate the mechanism of phosphorylation of apoptotic proteins and tests the hypothesis that the hypoxia-induced increased tyrosine phosphorylation of apoptotic proteins Bcl-2 and Bcl-xl is Ca(2+)-influx-dependent.
Phosphorylation (phosphorylation) of Bcl-xl associated with hypoxia and apoptosis
10) Confidence 0.08 Published 2010 Journal Neurochem. Res. Section Abstract Doc Link 19597709 Disease Relevance 0.87 Pain Relevance 0.21

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox